Business Context and Reporting Period
This Form 8-K filing by SS Innovations International, Inc. (formerly Avra Medical Robotics, Inc.) reports corporate governance changes effective July 30, 2023. The company is incorporated in Florida and identifies as an emerging growth company.
Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The report focuses exclusively on the appointment of new directors.
Material Changes
The Board of Directors expanded from four to five members. Two new independent directors were appointed to fill newly created vacancies:
- Dr. Mylswamy Annadurai: A distinguished space scientist with over 40 years of experience, including 36 years with the Indian Space Research Organization (ISRO). He previously served as Director of the ISRO Satellite Center and oversaw the development of 29 satellites.
- Prof. Dr. Somashekhar S.P.: A surgical oncologist and pioneer in robotic surgery in India. He currently serves as Global Director of the Aster International Institute of Oncology and has over 20 years of experience with Manipal Hospitals.
Outlook, Risks, and Management Commentary
Management believes the new directors' expertise in aerospace and robotic surgery will be valuable additions to the board. Both directors are deemed independent under SEC rules and Nasdaq listing standards. Each director has entered into an Indemnification Agreement with the company, providing indemnification to the fullest extent permitted by Florida law. No specific risks, contingencies, or forward-looking guidance regarding financial performance were disclosed in this filing.
Key Facts for Investor Verification
- Confirm the total number of board seats and the composition of the board following the July 30, 2023 expansion.
- Verify the independence status of Dr. Annadurai and Dr. Somashekhar S.P. against current Nasdaq listing standards.
- Review the specific terms of the Indemnification Agreements executed with the new directors.
- Check for any subsequent filings regarding the company's financial status, as this 8-K contains no financial data.